Method of preventing or treating metabolic syndrome
OwnerStephanie K. Lynch, Maciej Turowski +2inventors
InventorsStephanie K. Lynch, Maciej Turowski, Wallace Yokoyama, Jerry R. Conklin
Life of this patent
Estimating the term…
Abstract
Water-insoluble cellulose derivatives such as ethyl cellulose can be used to treat or prevent metabolic syndrome and/or one of the abnormalities of metabolic syndrome.
Claims21
A method of preventing or treating metabolic syndrome or a symptom or condition associated with the metabolic syndrome in an individual comprising the step of administering to the individual an effective amount of a water-insoluble cellulose derivative.
A method of preventing or treating one or more of the symptoms a) atherogenic dyslipidemia, b) insulin resistance, c) proinflammatory or inflammation state and d) prothrombotic state in an individual comprising the step of administering to the individual an effective amount of a water-insoluble cellulose derivative.
A method of influencing the level of expression or the concentration of C-reactive protein, of Plasminogen Activator Inhibitor-1, or of hepatic lipase or of two or three thereof in a body tissue of an individual comprising the step of administering to the individual an effective amount of a water-insoluble cellulose derivative.
A method of influencing the level of expression or the concentration of adiponectin in a body tissue of an individual comprising the step of administering to the individual an effective amount of a water-insoluble cellulose derivative.
A method of preventing or treating a cardiovascular disease or Type II diabetes in an individual comprising the step of administering to the individual an effective amount of a water-insoluble cellulose derivative.
A medicament, pharmaceutical composition, food, food ingredient or supplement, or nutraceutical ingredient or supplement comprising an effective amount of a water-insoluble cellulose derivative for preventing or treating metabolic syndrome or a symptom or condition associated with the metabolic syndrome.
A medicament, pharmaceutical composition, food, food ingredient or supplement, or nutraceutical ingredient or supplement comprising an effective amount of a water-insoluble cellulose derivative for preventing or treating one or more of the symptoms a) atherogenic dyslipidemia, b) insulin resistance, c) proinflammatory or inflammation state and d) prothrombotic state in an individual.
A medicament, pharmaceutical composition, food, food ingredient or supplement, or nutraceutical ingredient or supplement comprising an effective amount of a water-insoluble cellulose derivative for influencing the level of expression or the concentration of C-reactive protein, of Plasminogen Activator Inhibitor-1 or of hepatic lipase or of two or three thereof in a body tissue of an individual.
A medicament, pharmaceutical composition, food, food ingredient or supplement, or nutraceutical ingredient or supplement comprising an effective amount of a water-insoluble cellulose derivative for influencing the level of expression or the concentration of adiponectin in a body tissue of an individual.
A medicament, pharmaceutical composition, food, food ingredient or supplement, or nutraceutical ingredient or supplement comprising an effective amount of a water-insoluble cellulose derivative for preventing or treating a cardiovascular disease or Type II diabetes in an individual.
A medicament, pharmaceutical composition, food, food ingredient or supplement, or nutraceutical ingredient or supplement comprising ethyl cellulose as an active principle.
Dependencies are inferred from the claim text.